R-954, a bradykinin B1 receptor antagonist, as a potential therapy in a preclinical endometriosis model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

R-954, a bradykinin B1 receptor antagonist, as a potential therapy in a preclinical endometriosis model

Published:2024-11 Issue: Volume:181 Page:171294
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

França Patricia Ribeiro de Carvalho,Paiva João Pedro Barros de,Carvalho Rosangela Ribeiro de,Figueiredo Claudia Pinto,Sirois Pierre,Fernandes Patricia Dias

Funder

Coordination of Higher Education Personnel Improvement

National Council for Scientific and Technological Development

Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State

Publisher

Elsevier BV

Reference37 articles.

1. Endometriosis and Infertility: a Review of the pathogenesis and treatment of endometriosis-associated infertility;Macer;Obst Gynecol. Clin. North Am.,2012

2. Inflammation to infertility: panoramic view on endometriosis;Rasheed;Cureus,2020

3. Endometriosis in MRKH cases as a proof for the coelomic metaplasia hypothesis?;Konrad;Reproduction,2019

4. Pathogenesis of deep endometriosis;Gordts;Fertil. Steril.,2017

5. Stem cell theory for the pathogenesis of endometriosis;Maruyama;Front. Biosci.,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP